Chemistry: analytical and immunological testing – Peptide – protein or amino acid
Reexamination Certificate
2007-06-12
2007-06-12
Cole, Monique T. (Department: 1743)
Chemistry: analytical and immunological testing
Peptide, protein or amino acid
C436S173000, C702S022000, C702S023000, C702S027000
Reexamination Certificate
active
11225243
ABSTRACT:
A method for interpreting data that is produced after a group of amino acids and acylcarnitines are derivatized from blood spots taken from newborn babies and scanned by a tandem mass spectrometer. Concentration levels of each metabolite, which are directly proportional to the butyl ester fragment after derivatization, are compared to threshold flags for determining a significance of any deviation of the metabolite relative to the flag threshold. The threshold flags are diagnostic limits to the data retrieved from each blood spot. The data includes metabolite concentrations and molar ratios of metabolites with other metabolites. Samples are labeled normal for a disease if the concentration of any of the metabolite concentrations or molar ratio concentration do not deviate from the flag threshold, but, in contrast, the sample must be further evaluated if a value is elevated or deficient to some degree. Thus, as each metabolite fragments at a different mass to charge value (m/z), corresponding data is compared to the respective flag thresholds for determining a next course of action that must be taken to ultimately assist a physician in the diagnosis of a genetic disorder resulting from an elevation or deficiency of the metabolite particular for that disorder.
REFERENCES:
patent: 4224031 (1980-09-01), Mee et al.
patent: 5072115 (1991-12-01), Zhou
patent: 5206508 (1993-04-01), Alderice et al.
patent: 5251126 (1993-10-01), Kahn et al.
patent: 5252489 (1993-10-01), Macri
patent: 5316917 (1994-05-01), Roe
patent: 5352891 (1994-10-01), Monning et al.
patent: 5365426 (1994-11-01), Siegel et al.
patent: 5453613 (1995-09-01), Gray et al.
patent: 5538897 (1996-07-01), Yates et al.
patent: 5545895 (1996-08-01), Wright et al.
patent: 5629210 (1997-05-01), Hercules et al.
patent: 5878746 (1999-03-01), Lemelson et al.
patent: 6258605 (2001-07-01), Chace
patent: 6335369 (2002-01-01), Cavazza
patent: 6429230 (2002-08-01), Cavazza
patent: 6455321 (2002-09-01), Chace
patent: 6653349 (2003-11-01), Cavazza
patent: 6696492 (2004-02-01), Cavazza
patent: 6696493 (2004-02-01), Cavazza
C.G. Costa, et al., “Quantitative Analysis of Plasma Acylcarnitines Using Gas Chromatography Chemical Ionization Mass Fragmentometry,” Journal of Lipid Research, vol. 38, pp. 173-182 (1997).
Y. Shigematsu, et al., “Modifications in Electrospray Tandem Mass Spectrometry for a Neonatal-Screening Pilot Study in Japan,” Journal of Chromatography B, vol. 731, pp. 97-103 (1999).
K. Heinig, et al., “Determination of Carnitine and Acylcarnitines in Biological Samples by Capillary Electrophoresis-Mass Spectrometry,” Journal of Chromatography B, vol. 735, pp. 171-188 (1999).
B.M. Kelly et al., “Electrospray Mass Spectra of Medium-Chain and Long-Chain Acylcarnitines,” Organic Mass Spectrometry, vol. 27, pp. 924-926 (1992).
M.S. Rashed, et al., “Inborn Errors of Metabolism Diagnosed in Sudden Death Cases by Acylcarnitine Analysis of Postmortem Bile,” Clinical Chemistry, vol. 41 (8), pp. 1109-1114 (1995).
J.A. Montgomery, et al., “Measurement of Urinary Free and Acylcarnitines: Quantitative Acylcarnitine Profiling in Normal Humans and in Several Patients with Metabolic Errors,” Analytical Biochemistry, vol. 176 (1), pp. 85-95 (1989).
Chemical Abstract, vol. 128, No. 19, p. 323 , Abstract No. 228108p (1998), F. Inoue, et al., “Analysis of Dried Blood Spots by Electrospray Mass Spectrometry,” Bull. Kyoto Univ. Educ., Ser. B, vol. 91, pp. 15-22 (1997).
Chemical Abstract, vol. 123, No. 19, p. 508 , Abstract No. 250402y (1995), M.S. Rashed, et al., “Diagnosis of Inborn Errors of Metabolism from Blood Spots by Acylcarnitines and Amino Acids Profiling Using Automated Electrospray Tandem Mass Spectrometry,” Pediatr. Res., vol. 38(3), pp. 324-331 (1995).
Chemical Abstract, vol. 124, No. 5, p. 608 , Abstract No. 49898s (1996), N. Terada, et al., “Amino Acids and Acylcarnitines Analysis by ESLMS/MS” Nippon Iyo Masu Supekutoru Gakkai Koenshu, vol. 20, pp. 39-44 (1995).
Chemical Abstract, vol. 120, No. 13, p. 536 , Abstract No. 157900n (1994), M.S. Rashed, et al., “Electrospray Tandem Mass Spectrometry in the Diagnosis of Organic Acidemas,” Rapid Commun. Mass Spectrom., vol. 8(1), pp. 129-133 (1994).
Millington, D., et al; Diagnosis of Metabolic Disease,Biological Mass Spectrometry: Present and Future, 1994; pp. 559-579.
Millington, D., et al; Carnitine and Acylcarnitines in Metabolic Disease Diagnosis and Management;Mass Spectrometry: Clinical and Biomedical Applications, vol. 1; 1992; pp. 299-318.
Millington, D., et al; The Analysis of Diagnostic Markers of Genetic Disorders in Human Blood and Urine using Tandem Mass Spectrometry with Liquid Secondary Ion Mass Spectrometry;International Journal of Mass Spectrometry and Ion Processes, 111; 1991; pp. 211-228.
Van Hove, J., et al; Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: Diagnosis by Acylcarnitine Analysis in Blood;Am. J. Hum. Genet. S2; pp. 958-966.
Chace, D., et al; Rapid Diagnosis of Maple Syrup Urine Disease in Blood Spots from Newborns by Tandem Mass Spectrometry;Clinical Chemistry, vol. 41 (1); 1995; pp. 62-68.
Chace, D., et al; Rapid Diagnosis of Homocystinuria and Other Hypermethioninemias from Newborns' Blood Spots by Tandem Mass Spectrometry;Clinical Chemistry, vol. 42 (3); 1996; pp. 349-355.
Chace, D., et al; Rapid Diagnosis of Phenylketonuria by Quantitative Analysis for Phenylalanine and Tyrosine in Neonatal Blood Spots by Tandem Mass Spectrometry;Clinical Chemistry, vol. 39 (1); 1993; pp. 66-71.
Chace, D., et al; Rapid Diagnosis of MCAD Deficiency: Quantitative Analysis of Octanoylcarnitine and Other Acylcarnitines in Newborn Blood Spots by Tandem Mass Spectrometry;Clinical Chemistry, vol. 43 (11); 1997; pp. 2106-2113.
Chace, D., et al; Neonatal Screening for Inborn Errors of Metabolism by Automated Dynamic Liquid Secondary Ion Tandem Mass Spectrometry;New Horizons in Neonatal Screening; 1994; pp. 373-375.
Van Hove, J., et al; Acylcarnitines in Amniotic Fluid: Application to the Prenatal Diagnosis of Propionic Acidaemia;J. Inher. Metab. Dis16; 1993; pp. 361-367.
Van Hove, J., et al; Intravenous L-Carnitine and Acetyl-L-Carnitine in Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency and Isovaleric Acidemia;Pediatric Research, vol. 35 (1); 1994; pp. 96-101.
Shigematsu, Y., et al; Prenatal Diagnosis of Organic Acidemias Based on Amniotic Fluid Levels of Acylcarnitines;Pediatric Research, vol. 39 (4); 1996; pp. 680-683.
Chace, D., et al; Expansion of Newborn Screening Programs Using Automated Tandem Mass Spectrometry;MRDD Research Reviews, vol. 5; 1999; pp. 150-154.
Chace, D., et al; Validation of Accuracy-based Amino Acid Reference Materials in Dried-Blood Spots by Tandem Mass Spectrometry for Newborn Screening Assays;ClinicalChemistry, vol. 45 (8); 1999; pp. 1269-1277.
Chace, D., et al; Laboratory Integration And Utilization Of Tandem Mass Spectrometry In Neonatal Screening: A Model For Clinical Mass Spectrometry In The Next Millennium;Acta Paediatr Supp.,vol. 432; 1999; pp. 45-47.
Andresen, B., et al; Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutations Identified by MS/MS-Based Prospective Screening of Newborns Differ from Those Observed in Patients with Clinical Symptoms: Identification and Characterization of a New, Prevalent Mutation that Results in Mild MCAD Deficiency;Am. J. Hum. Genet. 68; 2001; pp. 1408-1418.
Naylor, E., et al; Automated Tandem Mass Spectrometry for Mass Newborn Screening for Disorders in Fatty Acid, Organic Acid, and Amino Acid Metabolism;Journal of Child Neurology, vol. 14, Supplement 1; Nov. 1999; pp. 84-88.
Adam, B., et al; Recoveries of Phenylalanine from Two Sets of Dried-Blood-Spot Reference Materials: Prediction from Hematocrit, Spot Volume, and Paper Matrix;Clinical Chemistry46 (1); 2000; pp. 126-128.
Kao, P., et al; Diagnosis of Adrenal Cortical Dysfunction by Liquid Chromatography-Tandem Mass Spectrometry;Annals of Clinical&Laboratory Science, vol. 31 (2); 2001; pp. 199-204.
Chace, D., et
Choate Hall and Stewart LLP
Cole Monique T.
Herschbach Jarrell Brenda
Lyon Charles E.
Pediatrix Screening, Inc.
LandOfFree
Method for interpreting tandem mass spectrometry data for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for interpreting tandem mass spectrometry data for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for interpreting tandem mass spectrometry data for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3858994